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Abstract: Background and objectives: Recurrent herpes simplex keratitis (HSK) is the most common
cause of corneal blindness in the developed world. A relationship between host gene polymorphisms
and the recurrence of herpes simplex virus (HSV) infection has previously been proposed. Thus,
the aim of this study was to investigate a potential association between the IL28B host genotype and
recurrent HSK. Materials and Methods: Eighty patients older than 18 years of age of both genders
with a history of recurrent herpes simplex labialis (HSL) were considered for inclusion. Seventy-five
of these patients were found to be seropositive for HSV-1 and were subsequently enrolled in the
study. Twenty-four of the enrolled patients also had a history of recurrent HSK associated with severe
corneal scarring and visual acuity deterioration. Total DNA was isolated from whole blood samples.
A single-nucleotide polymorphism (SNP) rs12979860 near the IL28B gene on chromosome 19 was
genotyped. Results: A significant association was observed between recurrent HSK and two SNPs of
the IL28B genotype (CCrs12979860 and CTrs12979860, p < 0.01). The variation CCrs12979860 showed
a significantly greater association with HSK (16 out of 26 patients) compared with CTrs12979860
(8 out of 34 patients). Conclusion: Seropositive individuals with a history of recurrent HSK are likely
to have the CC IL28B genotype. This genotype may be related to incomplete control of the infection
and more frequent periodical viral shedding along the first nerve branch of the trigeminal ganglion,
which clinically manifests as recurrent herpes keratitis. The clinical manifestation of recurrent HSV-1
infection seems to be influenced by polymorphism of the IL28B genotype.
Keywords: type III interferons (IL28B) genotype; keratitis; herpes simplex virus type 1 (HSV-1)
1. Introduction
Herpes simplex virus (HSV) infection is ubiquitous in humans, infecting 50–90% of the world’s
population [1,2]. HSV-1 causes a wide range of diseases, including herpes labialis, gingivostomatitis,
and keratitis. The prevalence of ocular HSV disease has been estimated to be 149 in a population of
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100,000 and in about one-fifth of the cases, leads to the development of stromal herpetic keratitis [3].
Herpes simplex keratitis (HSK) is one of the leading causes of corneal blindness, primarily because of
its recurrent nature [4].
After primary infection of the sensory nerves innervating the skin and mucosal epithelium, HSV-1
has the ability to establish lifelong latency, most commonly within the trigeminal ganglion. The HSV-1
virus uses actin and microtubules for retrograde transport from the plasma membrane during entry and
exit along axons. The composition of the viral particles, especially their protein complement, seems to
determine the direction of transport during the entry and exit of the virus in neuronal and non-neuronal
cells [5]. It has been estimated that one-third of the world’s population suffers from recurrent HSV
infections [3]. Upon periodical reactivation, the virus may follow any of the three branches of the fifth
cranial nerve, regardless of the innervation branch of the primary HSV infection area. It is believed
that cycles of HSV reactivation in latently infected neurons accompanied by anterograde axonal spread
to the cornea lead to recurrent infections and scarring of the cornea [6]. Antiviral cytokine secretion as
a result of host immunity plays a vital role in virus clearance; however, the concurrent inflammatory
response is a major cause of corneal scarring, leading to vision loss [2,3,7].
The production of Type I interferons (IFNs) is most important for controlling viral replication [8].
Accordingly, enhanced HSV virulence has been reported in Type I IFN-receptor-deficient mice [9].
Interleukin (IL) 28B (interferon (IFN)-λ3), together with IL-28A and IL-29 (also termed IFN-λ1 and
IFN-λ2) constitute a new subfamily within the IL-10 interferon family [10]. Indeed, IFN-λ exhibits a
number of biological characteristics that are similar to those of IFN-α/β, including antiviral activity,
antiproliferative activity, and in vivo antitumor activity. By signaling through the heterodimeric
IL-28Rα/IL–10Rβ complex, IFN-λ performs antiviral and immunoregulatory activities [11,12]. It has
also been shown that IFN-λ-mediated antiviral activity is linked to the activation of type I IFN-stimulated
gene factor 3 (ISGF3) and the induction of IFN-α/β- and IFN-λ-stimulated antiviral genes [13]. This
provides a potential mechanism for the inhibitory effect of IFN-λ on HSV-1. Additionally, IFN-λ has
the ability to activate the same JAK-STAT (Janus kinase-signal transducer and activator transcription
factor) and MAP (mitogen-activated protein) kinase pathway as Type I IFNs [14–16].
Recent studies have reported a relationship between a specific polymorphism of IL28B (rs12979860)
and HSV-1 reactivation in patients with herpes labialis [17], suggesting that polymorphisms in genes
involved in antiviral responses might modulate the risk of developing recurrent HSV infection. Of
note, this polymorphism was also reported to have a positive correlation with IFN-λ3 serum levels and
the treatment outcome in patients with hepatitis C virus infection [18,19]. Treatment with IFN-λ also
inhibited virus replication and inflammatory reaction in an experimental model of HSK in mice [20].
The aim of this study was to evaluate possible correlations between host polymorphisms of the
IL28B genotype and recurrent HSV keratitis in HSV-1 IgG-seropositive patients. To the best of our
knowledge, the potential relationship between IL28B genotype and recurrent HSK has not previously
been previously reported.
2. Materials and Methods
2.1. Study Setting
This was an in vitro experimental study using material of human origin. The study was conducted
in accordance with the Institutional Review Board regulations, adhered to the tenets of the Declaration
of Helsinki, and informed consent was obtained from all participants.
The sample consisted of 80 patients over the age of 18 of both genders. All participants filled out a
questionnaire to confirm their history of recurrent herpes simplex labialis (HSL) infection (cold sores).
In addition, blood samples were collected from all patients in order to confirm the HSV1 IgG-positive
status. Seventy-five of the tested patients were seropositive for HSV-1 and were subsequently enrolled
in the study.
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Twenty-four of the enrolled patients also had a history of recurrent HSV keratitis, leading to
severe corneal scarring and, consequently, visual acuity deterioration. Recurrences were classified as
epithelial keratitis, stromal keratitis, endothelitis, iridocyclitis, or combinations of these conditions.
All patients were followed up for at least one year, from January to December 2018, at the Clinic for
Eye Diseases, Clinical Centre of Serbia, Belgrade. Participants with no history of herpetic eye disease
were voluntary employees from the Scientific Institute of Veterinary Medicine of Serbia. Genotyping
for IL28B (rs12979860snp) was performed in the laboratory of the Scientific Institute of Veterinary
Medicine of Serbia.
2.2. Inclusion and Exclusion Criteria
The study included participants with a history of recurrent HSL infection and confirmed HSV-1
IgG-seropositive status. Participants lacking anti-HSV-1 IgG antibodies were excluded (5 out of 80).
This selection step resulted in a main study sample of 75 subjects.
Inclusion criteria for patients exhibiting recurrent herpetic eye disease were as follows: recurrent
herpetic keratitis associated with corneal scarring and neovascularization and significant deterioration
of visual acuity (less than 6/60, Snellen).
Exclusion criteria were as follows: a history of associated ocular comorbidities and previous
ocular surgery, systemic and neurological diseases.
2.3. Immunological Analyses
Five milliliters of peripheral venous blood was collected from each patient in order to identify
HSV-1 IgG status. An enzyme immunoassay was conducted for the qualitative determination of IgG
class antibodies against HSV Type 1+2 in human serum or plasma (GenWay Biotech, Inc., San Diego,
CA, USA). The cut-off value was HSV1 IgG < 9NTU.
2.4. Determination of IL28B Genotype
Five milliliters of peripheral venous blood was collected from each patient in order to identify the
polymorphic gene IL28B rs12979860.
Total DNA was isolated using a commercial QIAamp DNA Blood mini kit (QIAGEN, Hilden,
Germany) in accordance with the manufacturer’s instructions. The single-nucleotide polymorphism
(SNP) rs12979860, near the IL28B gene on chromosome 19, was genotyped.
Polymorphism was evaluated using the Sequence-Specific Primer-Polymerase Chain Reaction
(SSP-PCR) method, which multiplies a short DNA region upstream or downstream of the polymorphism
with an allele-specific primer (Table 1) [21]. PCR products were analyzed in 2% agarose gel with
ethidium bromide staining (Figure 1). Determination of individual-polymorphism genotypes was
performed on the basis of the presence or absence of amplified target sequences. The amplification
was performed using the following parameters: initial denaturation step at 95 ◦C for 5 min, then 35
cycles at 95 ◦C for 30 s, 58 ◦C for 45 s, 72 ◦C for 60 s, and 72 ◦C for 10 min.
Table 1. Nucleotide sequences of the primers used in this study. SNP: single-nucleotide polymorphism.
IL28B SNP Nucleotide Sequence Size of PCR Product
rs12979860
Gen (sense) 5′-TTATCGCATACGG CTAGGC-3′
153 bpC (antisense) 5′TGCAATTCAACCCTGGTTC G-3′
T (antisense) 5′ TGCAATTCAACCCTGGTTC A-3
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Figure 1. Polymorphism rs12979860—determination of genotypes (size of PCR product: 153 bp). Line
1, DNA ladder; lanes 2,3, TT homozygous; lanes 4,5, CC homozygous, Lines 6,7, CT heterozygous.
Heterozygous samples resulted in the amplification of both bands, indicating the presence of the
two alleles.
2.5. Ethical Approval
This study was approved by the Ethics Committee and the Institutional Review Board of Clinical
Center of Serbia, Belgrade (decision No. 57/14, approved on 21 March 2019). Please mention that the
study was done according to the Helsinki declaration.
2.6. Statistical Analysis
The statistical analysis was performed with SPSS Statistics 20. We used the Chi-square test to
determine if there was an association between IL28b genotypes and prevalence of HSV infections.
The Chi-square independence test was applied in order to determine a possible association between
IL28b genotypes and incidence of HSK infection; p-values below 0.01 were considered statistically
significant. The calculation of the total sample was based on the results of other authors who had
studied the impact of the examined genotype in subjects with labial herpes and patients with hepatitis
C. Using a G*Power 3.1.9.4 and χ2 test with a significance level (alpha) of 0.01 and a study strength of
0.08, it was deemed that a minimum number of 40 subjects was required to achieve significant results.
The total sample size comprised 75 respondents; thus, the sample size was sufficient.
3. Results
3.1. Clinical Characteristics
This study included 75 participants with confirmed HSV IgG-positive status. Twenty-four patients
had experienced recurrent HSK, and the remaining 51 individuals only had a history of recurrent HSL
disease. The demographic characteristics of the study population are summarized in Table 2.
Table 2. Demographic characteristics of the study population.
Characteristics All Patients
n 75
Gender (M/F) 36:39
Age, y 44.95 ± 11.294
Have keratitis (M) 5 (6.7%)
Do not have keratitis (M) 31 (41.3%)
Have keratitis (F) 19 (25.3%)
Do not have keratitis (F) 20 (26.7%)
Data are reported as mean ± standard deviation. M, male; F, female.
3.2. Distribution of IL28B Genotype Polymorphisms
The presence of the host IL28B rs1279860 genotype was investigated in all participants. The
distribution of the polymorphism in the IL28B gene region for the study population as a whole is shown
in Figure 2. CTrs1279860 was the most common genotype identified and was estimated to be present
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in 45% of patients (34 out of 75), followed by the CCrs1279860 genotype, present in 35%of patients
(26 patients), and the TTrs1279860 genotype, observed in the remaining 20% of patients (15 patients)
(Figure 2).Medicina 2019, 55, x FOR PEER REVIEW 5 of 10 
 
Figure 2. Distribution of the IL28B genotype rs12979860 in the study group as a whole. Percent 
distribution of the IL28B genotype rs12979860. CC: CCrs1279860, CT: CTrs1279860, TT: TTrs1279860. 
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Figure 2. Distribution of the IL28B genotype rs12979860 in the study group as a whole. Percent
distribution of the IL28B genotype rs12979860. CC: CCrs1279860, CT: CTrs1279860, TT: TTrs1279860.
A significant association was observed between recurrent HSV keratitis and two SNPs of the IL28B
genotype (CCrs12979860 and CTrs12979860, p < 0.01). Interestingly, the variation in CCrs12979860
showed a more significant association with recurrent HSV keratitis compared with CTrs12979860
(16 and 8 patients, respectively), as demonstrated in Figure 3. Furthermore, the TTrs12979860 genotype
variant of IL28B was observed in 15 participants with HSV labialis disease. Of note, in our study,
patients with recurrent HSV keratitis did not show the TTrs12979860 genotype variant (Figure 3).
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4. Discussion
In our study, the polymorphism of the IL28B (rs12979860) gene was analyzed in HSV-1-seropositive
patients with a history of recurrent HSV disease including HSV keratitis and/or herpes labialis. The
CTrs12979860 genotype was the most common SNP variation in patients with recurrent HSV disease,
followed by the CCrs12979860 and the TTrs12979860 genotypes. Interestingly, the majority of patients
with recurrent HSV keratitis demonstrated the CC genotype (16 out of 24, 66.7%), whereas only 10 out
of 51 (19.6%) individuals with herpes labialis (without a history of recurrent HSV eye disease) showed
the CC genotype variant of IL28B.
Recurrent stromal HSV keratitis is recognized as the most common infectious cause of
vision-threatening corneal scarring in the developed world [22]. Accordingly, in our study, all
patients with recurrent HSV keratitis exhibited severe corneal scarring accompanied by significant
visual acuity reduction. The inflammatory process orchestrated by Th1 cells and non-lymphoid
inflammatory cells leads to a chronic tissue-damaging response in addition to direct viral effects [4].
Most of the corneal damage results from neutrophil infiltration and neovascularization [23].
Studies with animal models have revealed that the genetic make-up of the host has an impact on
the severity of HSV-1 corneal disease. Strains of inbred mice were shown to differ in their susceptibility
to HSV corneal infection [24]. However, the roles of specific host genes in the resistance to HSK are
poorly understood. Host genes may influence the outcome of an infection by affecting innate resistance
factors as well as the function of the immune system [25]. It was also shown that susceptibility to HSV-1
infection is modulated by polymorphisms in genes that control the effector functions of cytotoxic T
and natural killer (NK) lymphocytes [26].
A number of studies have investigated the relationship among host gene polymorphisms and
both the severity and the recurrence of HSV infection [17,26,27]. In this context, it was recently
reported that IFN-λ gene expression is associated with the recurrence and severity of recurrent HSV-1
disease [17]. Indeed, the minor T allele at rs12979860 was found to be associated with the severity
and frequency of labial herpes recurrence. Griffiths et al. found that individuals with the CT or TT
genotypes for IL28B had more frequent episodes of severe labial herpes, a condition resulting from the
reactivation of HSV-1 [17]. On the basis of these findings, the authors suggested that recurrent HSV
disease is likely to be associated with the IL28B polymorphism. Likewise, in our study, the CT and TT
genotypes were more prevalent in individuals with isolated labial herpes. However, the CC genotype
for IL28B was highly associated with recurrent HSK. It seems that both clinical manifestation and site
of HSV reactivation from trigeminal ganglia might be related to different host genotypes as well as to
the micro-environment. It is therefore of utmost clinical interest to identify a subgroup of patients
with recurrent HSL who possess a higher risk for developing HSK, a potentially blinding disorder.
Future studies with larger numbers of participants are necessary to confirm the hypothesis that the
host genotype of IL28B might have an influence on determining which one of the three branches of
trigeminal ganglion is most likely to be followed upon periodical HSV reactivation.
In patients with chronic hepatitis C, the CC genotype profile has been associated with a lower
level of transcription of interferon-stimulated genes (ISGs) compared with TT individuals [28,29]. The
non-CC genotypes, associated with a higher level of ISG expression in the setting of chronic hepatitis C
infection, have previously been related to lower rates of spontaneous virus clearance. In contrast, the
CC genotype, in which a low level ISG expression is observed, has been associated with high rates of
spontaneous virus clearance [28].
The presence of the CC genotype variant in our patients with recurrent HSK might have led to
incomplete control of infection and periodical viral shedding due to a lower transcription level of ISGs,
as previously reported in patients with chronic hepatitis C infection [28,29].
Type III IFNs (IFN-λ) have been found to possess antiviral effects against HSV [30,31]. Pica et
al. reported that reduced production of IFN-λ might be correlated with the development of recurrent
HSV-1 labialis in immunocompetent individuals [32]. A recent study reported that IFN-λ treatment
resulted in significant suppression of HSV-1 replication in both astrocytes and neurons. Furthermore,
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this was associated with the upregulation of endogenous IFN-α/β and several ISGs [13]. These findings
indicate that IFN-λ functionally resembles that of type I IFN, inducing ISG expression and resulting in
the suppression of viral replication [13]. Immunological control of virus reactivation should also be
taken into account. The environmental and physiologic stimuli that induce HSV-1 reactivation from
latency include exposure to UV light, stress, and immune suppression, suggesting a possible role for T
cells in preventing viral reactivation [33].
5. Conclusions
In our study, the CTrs12979860 genotype was found to be the most common SNP variation in
patients with recurrent HSV disease, followed by CCrs12979860 and TTrs12979860.
While the CT and TT genotypes were more prevalent in individuals with isolated labial herpes, our
results indicate that HSV-1-seropositive individuals expressing the CC IL28B genotype have a tendency
toward developing recurrent herpetic keratitis. Clinical manifestation and the severity of recurrent
HSV-1 infection seem to be influenced by polymorphism of the IL28B genotype. Further studies on
host genetics in patients with recurrent herpetic eye disease are necessary to support our results.
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